Testing

News

Details: Category: POZ.com; Published: 12 March 2021

Unlike previous years, webcasts of HIV and COVID-19 research presentations from CROI 2021 remain behind a paywall.

Created: 12 March 2021

Last Updated: 12 March 2021

Details: Category: POZ.com; Published: 03 March 2021

Abbott researchers found a high proportion of elite HIV controllers in the Democratic Republic of Congo, which could lead to cure insights.

Created: 03 March 2021

Last Updated: 03 March 2021

Details: Category: POZ.com; Published: 26 February 2021

During the June meeting, U.N. leaders will assess global progress toward ending AIDS by 2030. Also: This year marks 25 years of UNAIDS.

Created: 26 February 2021

Last Updated: 26 February 2021

Details: Category: POZ.com; Published: 19 February 2021

Andrew Spieldenner, PhD, is the new executive director of MPact Global Action for Gay Men’s Health and Rights.

Created: 19 February 2021

Last Updated: 19 February 2021

Details: Category: POZ.com; Published: 13 January 2021

The second cohort of U=U Ambassadors officially join Prevention Access Campaign to help educate and empower communities about HIV and U=U

Created: 13 January 2021

Last Updated: 13 January 2021

Details: Category: POZ.com; Published: 12 January 2021

Contradicting a previous study, new data on injectable contraceptives suggest the vaginal microbiome may increase susceptibility to HIV.

Created: 12 January 2021

Last Updated: 12 January 2021

Details: Category: POZ.com; Published: 11 January 2021

People with HIV and ulcerative colitis or Crohn’s disease may need less IBD medication and have fewer hospitalizations.

Created: 11 January 2021

Last Updated: 11 January 2021

Details: Category: POZ.com; Published: 30 December 2020

Researchers found that Truvada as pre-exposure prophylaxis greatly reduced HIV cases in both people on PrEP and those not on it.

Created: 30 December 2020

Last Updated: 30 December 2020

Details: Category: POZ.com; Published: 25 December 2020

Globally, a child contracts HIV every 100 seconds. A new, affordable treatment is available, but the COVID-19 pandemic hinders access.

Created: 25 December 2020

Last Updated: 25 December 2020

Details: Category: POZ.com; Published: 24 December 2020

The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.

Created: 24 December 2020

Last Updated: 24 December 2020

Details: Category: POZ.com; Published: 23 December 2020

If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Created: 23 December 2020

Last Updated: 23 December 2020

Details: Category: POZ.com; Published: 23 December 2020

If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Contacts

News

News

After Pushback, the HIV and COVID-19 Conference CROI Makes Some Materials Public [VIDEO]

Scientists Discover Large Group of People Who Control HIV Without Meds

United Nations General Assembly to Hold a High-Level Meeting on HIV/AIDS

Meet the HIV Activist Who’ll Lead MPact, a Global Gay Men’s Health Group

PAC Welcomes U=U Ambassadors

Injectable Contraceptives May Impact HIV Acquisition, but Only for Some Women

People With HIV May Fare Better With Inflammatory Bowel Disease

In Scotland, PrEP Is Tied to Population-Level Decline in HIV

Good and Bad News About HIV Treatment for Children

Long-Acting Injectable HIV Regimen Approved in Europe

Lawsuit Is Filed Against Trump Ban on LGBT and HIV-Positive Asylum Seekers

Lawsuit Filed Against Trump Ban on LGBT and HIV-Positive Asylum Seekers

Subcategories

Fundraisers Article Count: 2

Health Article Count: 4

HIV / AIDS Article Count: 4

Partners Article Count: 387

POZ.com Article Count: 386

POZ Stories Article Count: 50